nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—bone cancer	0.193	0.253	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—bone cancer	0.107	0.14	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—bone cancer	0.103	0.134	CbGbCtD
Ofloxacin—ABCC2—Carboplatin—bone cancer	0.0735	0.0962	CbGbCtD
Ofloxacin—ABCC2—Cisplatin—bone cancer	0.0628	0.0822	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—bone cancer	0.0569	0.0745	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—bone cancer	0.0551	0.0721	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—bone cancer	0.0421	0.0551	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—bone cancer	0.0408	0.0534	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—bone cancer	0.0298	0.0391	CbGbCtD
Ofloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00489	0.128	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00283	0.0741	CbGpPWpGaD
Ofloxacin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00216	0.0566	CbGpPWpGaD
Ofloxacin—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0019	0.0498	CbGpPWpGaD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00178	0.0466	CbGpPWpGaD
Ofloxacin—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.00121	0.0318	CbGpPWpGaD
Ofloxacin—ABCC1—Irinotecan Pathway—CYP3A4—bone cancer	0.0012	0.0314	CbGpPWpGaD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00104	0.0272	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00102	0.0268	CbGpPWpGaD
Ofloxacin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—bone cancer	0.000956	0.0251	CbGpPWpGaD
Ofloxacin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000793	0.0208	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000709	0.0186	CbGpPWpGaD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000701	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000701	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000701	0.173	CbGdCrCtD
Ofloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00067	0.0176	CbGpPWpGaD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000649	0.16	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000649	0.16	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000649	0.16	CbGdCrCtD
Ofloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000626	0.0164	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000597	0.0156	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00055	0.0144	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000474	0.0124	CbGpPWpGaD
Ofloxacin—Levofloxacin—CYP3A4—bone cancer	0.000431	0.36	CrCbGaD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—bone cancer	0.000416	0.0109	CbGpPWpGaD
Ofloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000416	0.348	CrCbGaD
Ofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000409	0.0107	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000383	0.01	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000372	0.00976	CbGpPWpGaD
Ofloxacin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000357	0.00935	CbGpPWpGaD
Ofloxacin—Norfloxacin—CYP3A4—bone cancer	0.000349	0.292	CrCbGaD
Ofloxacin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000342	0.00897	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000334	0.00874	CbGpPWpGaD
Ofloxacin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000329	0.00863	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000328	0.0086	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000305	0.008	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000304	0.00796	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000302	0.00792	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000288	0.00755	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000287	0.00753	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000258	0.00677	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000257	0.00673	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000249	0.00653	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000242	0.00634	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000235	0.00616	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000228	0.00596	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000227	0.00594	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000226	0.00592	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000224	0.00587	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000218	0.00571	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000217	0.00568	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000214	0.00561	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000211	0.00554	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000197	0.00517	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000196	0.00515	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000195	0.0051	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000193	0.00506	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000192	0.00503	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000185	0.00484	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000179	0.00469	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.000176	0.00463	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000176	0.00461	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000175	0.00459	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000171	0.00448	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000159	0.00417	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000159	0.00417	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000152	0.00399	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000148	0.00387	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000142	0.00373	CbGpPWpGaD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00014	0.00368	CbGpPWpGaD
Ofloxacin—Haemoglobin—Epirubicin—bone cancer	0.000136	0.000704	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—bone cancer	0.000136	0.000704	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—bone cancer	0.000136	0.000704	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—bone cancer	0.000135	0.000703	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.000135	0.000702	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—bone cancer	0.000135	0.000701	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—bone cancer	0.000135	0.000701	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—bone cancer	0.000135	0.0007	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—bone cancer	0.000135	0.000698	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—bone cancer	0.000134	0.000697	CcSEcCtD
Ofloxacin—Asthenia—Cisplatin—bone cancer	0.000134	0.000696	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—bone cancer	0.000134	0.000696	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—bone cancer	0.000134	0.000695	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—bone cancer	0.000133	0.000692	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—bone cancer	0.000133	0.00069	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—bone cancer	0.000133	0.000689	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—bone cancer	0.000133	0.000689	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000133	0.00348	CbGpPWpGaD
Ofloxacin—Urethral disorder—Epirubicin—bone cancer	0.000132	0.000687	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000132	0.000683	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—bone cancer	0.000131	0.000681	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—bone cancer	0.000131	0.00068	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—bone cancer	0.000131	0.000678	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—bone cancer	0.00013	0.000677	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—bone cancer	0.00013	0.000675	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—bone cancer	0.00013	0.000675	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.00013	0.000674	CcSEcCtD
Ofloxacin—Chills—Methotrexate—bone cancer	0.00013	0.000672	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000129	0.00338	CbGpPWpGaD
Ofloxacin—Diarrhoea—Cisplatin—bone cancer	0.000128	0.000663	CcSEcCtD
Ofloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000128	0.000663	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—bone cancer	0.000128	0.000662	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000127	0.00334	CbGpPWpGaD
Ofloxacin—Bradycardia—Doxorubicin—bone cancer	0.000127	0.00066	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—bone cancer	0.000127	0.000656	CcSEcCtD
Ofloxacin—Eye disorder—Epirubicin—bone cancer	0.000126	0.000655	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—bone cancer	0.000126	0.000654	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—bone cancer	0.000126	0.000652	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—bone cancer	0.000126	0.000652	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—bone cancer	0.000126	0.000652	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—bone cancer	0.000125	0.000651	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—bone cancer	0.000125	0.000651	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—bone cancer	0.000125	0.00065	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000125	0.00328	CbGpPWpGaD
Ofloxacin—Hepatitis—Doxorubicin—bone cancer	0.000125	0.000649	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—bone cancer	0.000125	0.000649	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—bone cancer	0.000124	0.000645	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—bone cancer	0.000124	0.000644	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000124	0.00324	CbGpPWpGaD
Ofloxacin—Urinary tract disorder—Doxorubicin—bone cancer	0.000123	0.00064	CcSEcCtD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000123	0.00323	CbGpPWpGaD
Ofloxacin—Oedema peripheral—Doxorubicin—bone cancer	0.000123	0.000639	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—bone cancer	0.000123	0.000638	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—bone cancer	0.000123	0.000637	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—bone cancer	0.000123	0.000636	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—bone cancer	0.000123	0.000636	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000122	0.00321	CbGpPWpGaD
Ofloxacin—Immune system disorder—Epirubicin—bone cancer	0.000122	0.000633	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—bone cancer	0.000122	0.000632	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—bone cancer	0.000122	0.000631	CcSEcCtD
Ofloxacin—Chills—Epirubicin—bone cancer	0.000121	0.000629	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—bone cancer	0.000121	0.000626	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—bone cancer	0.00012	0.000625	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—bone cancer	0.000119	0.000619	CcSEcCtD
Ofloxacin—Vomiting—Cisplatin—bone cancer	0.000119	0.000617	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—bone cancer	0.000118	0.000614	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—bone cancer	0.000118	0.000614	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—bone cancer	0.000118	0.000613	CcSEcCtD
Ofloxacin—Rash—Cisplatin—bone cancer	0.000118	0.000611	CcSEcCtD
Ofloxacin—Dermatitis—Cisplatin—bone cancer	0.000118	0.000611	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—bone cancer	0.000118	0.00061	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—bone cancer	0.000118	0.00061	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—bone cancer	0.000117	0.000606	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—bone cancer	0.000117	0.000605	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—bone cancer	0.000117	0.000605	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—bone cancer	0.000116	0.000603	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—bone cancer	0.000116	0.000602	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—bone cancer	0.000116	0.000602	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—bone cancer	0.000116	0.000601	CcSEcCtD
Ofloxacin—Tension—Epirubicin—bone cancer	0.000115	0.000599	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000115	0.00302	CbGpPWpGaD
Ofloxacin—Dysgeusia—Epirubicin—bone cancer	0.000115	0.000598	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—bone cancer	0.000114	0.000593	CcSEcCtD
Ofloxacin—Back pain—Epirubicin—bone cancer	0.000114	0.00059	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—bone cancer	0.000113	0.000588	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—bone cancer	0.000113	0.000588	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—bone cancer	0.000113	0.000587	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—bone cancer	0.000113	0.000586	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—bone cancer	0.000113	0.000586	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—bone cancer	0.000113	0.000584	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—bone cancer	0.000113	0.000584	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—bone cancer	0.000112	0.000582	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—bone cancer	0.000112	0.000579	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000111	0.00292	CbGpPWpGaD
Ofloxacin—Nausea—Cisplatin—bone cancer	0.000111	0.000576	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—bone cancer	0.000111	0.000575	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—bone cancer	0.00011	0.000573	CcSEcCtD
Ofloxacin—Cough—Methotrexate—bone cancer	0.00011	0.000569	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—bone cancer	0.00011	0.000568	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000109	0.00287	CbGpPWpGaD
Ofloxacin—Ill-defined disorder—Epirubicin—bone cancer	0.000109	0.000566	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—bone cancer	0.000109	0.000565	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—bone cancer	0.000109	0.000565	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—bone cancer	0.000109	0.000564	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—bone cancer	0.000108	0.000561	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000108	0.00283	CbGpPWpGaD
Ofloxacin—Flatulence—Doxorubicin—bone cancer	0.000107	0.000556	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—bone cancer	0.000107	0.000555	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—bone cancer	0.000107	0.000555	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—bone cancer	0.000107	0.000555	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—bone cancer	0.000107	0.000554	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000107	0.0028	CbGpPWpGaD
Ofloxacin—Dysgeusia—Doxorubicin—bone cancer	0.000107	0.000553	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000106	0.000551	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—bone cancer	0.000106	0.00055	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000106	0.00278	CbGpPWpGaD
Ofloxacin—Discomfort—Methotrexate—bone cancer	0.000106	0.000548	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—bone cancer	0.000106	0.000548	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—bone cancer	0.000106	0.000548	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—bone cancer	0.000105	0.000547	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—bone cancer	0.000105	0.000546	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—bone cancer	0.000105	0.000546	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—bone cancer	0.000105	0.000543	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—bone cancer	0.000104	0.000539	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—bone cancer	0.000103	0.000537	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—bone cancer	0.000103	0.000536	CcSEcCtD
Ofloxacin—Cough—Epirubicin—bone cancer	0.000103	0.000532	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—bone cancer	0.000103	0.000532	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—bone cancer	0.000103	0.000532	CcSEcCtD
Ofloxacin—Infection—Methotrexate—bone cancer	0.000102	0.000529	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—bone cancer	0.000102	0.000527	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—bone cancer	0.000101	0.000524	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—bone cancer	0.000101	0.000522	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—bone cancer	0.000101	0.000522	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—bone cancer	0.0001	0.000521	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—bone cancer	0.0001	0.000519	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—bone cancer	0.0001	0.000519	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—bone cancer	0.0001	0.000519	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—bone cancer	0.0001	0.000519	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—bone cancer	9.98e-05	0.000518	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—bone cancer	9.96e-05	0.000517	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	9.95e-05	0.000516	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—bone cancer	9.92e-05	0.000514	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—bone cancer	9.89e-05	0.000513	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.84e-05	0.00258	CbGpPWpGaD
Ofloxacin—Malaise—Doxorubicin—bone cancer	9.82e-05	0.000509	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—bone cancer	9.79e-05	0.000508	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—bone cancer	9.78e-05	0.000507	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—bone cancer	9.78e-05	0.000507	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—bone cancer	9.76e-05	0.000506	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—bone cancer	9.74e-05	0.000505	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—bone cancer	9.68e-05	0.000502	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—NDUFA12—bone cancer	9.66e-05	0.00253	CbGpPWpGaD
Ofloxacin—Palpitations—Doxorubicin—bone cancer	9.62e-05	0.000499	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—bone cancer	9.6e-05	0.000498	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—bone cancer	9.6e-05	0.000498	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—bone cancer	9.59e-05	0.000497	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—bone cancer	9.57e-05	0.000496	CcSEcCtD
Ofloxacin—Infection—Epirubicin—bone cancer	9.54e-05	0.000495	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—bone cancer	9.5e-05	0.000493	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	9.49e-05	0.00249	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	9.48e-05	0.00248	CbGpPWpGaD
Ofloxacin—Shock—Epirubicin—bone cancer	9.45e-05	0.00049	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—bone cancer	9.41e-05	0.000488	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—bone cancer	9.4e-05	0.000488	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—bone cancer	9.4e-05	0.000487	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—bone cancer	9.37e-05	0.000486	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	9.35e-05	0.000485	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—bone cancer	9.33e-05	0.000484	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—bone cancer	9.28e-05	0.000481	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—bone cancer	9.28e-05	0.000481	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—bone cancer	9.27e-05	0.000481	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—bone cancer	9.27e-05	0.000481	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—bone cancer	9.27e-05	0.000481	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—bone cancer	9.23e-05	0.000479	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—bone cancer	9.21e-05	0.000478	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	9.2e-05	0.000477	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—bone cancer	9.16e-05	0.000475	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—bone cancer	9.15e-05	0.000475	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—bone cancer	9.15e-05	0.000474	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	9.14e-05	0.0024	CbGpPWpGaD
Ofloxacin—Somnolence—Methotrexate—bone cancer	9.12e-05	0.000473	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—bone cancer	9.06e-05	0.00047	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—bone cancer	9.03e-05	0.000468	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—bone cancer	8.97e-05	0.000465	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—bone cancer	8.96e-05	0.000465	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.95e-05	0.00235	CbGpPWpGaD
Ofloxacin—Decreased appetite—Methotrexate—bone cancer	8.92e-05	0.000463	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—bone cancer	8.88e-05	0.000461	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—bone cancer	8.88e-05	0.000461	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—bone cancer	8.86e-05	0.000459	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—bone cancer	8.84e-05	0.000459	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—bone cancer	8.83e-05	0.000458	CcSEcCtD
Ofloxacin—Pain—Methotrexate—bone cancer	8.77e-05	0.000455	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	8.75e-05	0.000454	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—bone cancer	8.74e-05	0.000453	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—bone cancer	8.71e-05	0.000452	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—bone cancer	8.7e-05	0.000451	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—bone cancer	8.68e-05	0.00045	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—bone cancer	8.67e-05	0.00045	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—bone cancer	8.63e-05	0.000448	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—bone cancer	8.62e-05	0.000447	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—bone cancer	8.59e-05	0.000445	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—bone cancer	8.56e-05	0.000444	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	8.56e-05	0.00224	CbGpPWpGaD
Ofloxacin—Somnolence—Epirubicin—bone cancer	8.53e-05	0.000443	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—bone cancer	8.47e-05	0.000439	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—bone cancer	8.45e-05	0.000438	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—bone cancer	8.45e-05	0.000438	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—bone cancer	8.39e-05	0.000435	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—bone cancer	8.35e-05	0.000433	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—bone cancer	8.3e-05	0.000431	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—bone cancer	8.29e-05	0.00043	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—bone cancer	8.28e-05	0.000429	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	8.21e-05	0.00215	CbGpPWpGaD
Ofloxacin—Constipation—Epirubicin—bone cancer	8.21e-05	0.000426	CcSEcCtD
Ofloxacin—Pain—Epirubicin—bone cancer	8.21e-05	0.000426	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—bone cancer	8.15e-05	0.000423	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—bone cancer	8.11e-05	0.000421	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—bone cancer	8.11e-05	0.000421	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	8.09e-05	0.00042	CcSEcCtD
Ofloxacin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	8.08e-05	0.00212	CbGpPWpGaD
Ofloxacin—Insomnia—Doxorubicin—bone cancer	8.03e-05	0.000417	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—NT5C3A—bone cancer	8.01e-05	0.0021	CbGpPWpGaD
Ofloxacin—Paraesthesia—Doxorubicin—bone cancer	7.98e-05	0.000414	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—bone cancer	7.92e-05	0.000411	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—bone cancer	7.91e-05	0.00041	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—bone cancer	7.9e-05	0.00041	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—bone cancer	7.85e-05	0.000407	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—bone cancer	7.82e-05	0.000406	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.79e-05	0.00204	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	7.75e-05	0.00203	CbGpPWpGaD
Ofloxacin—Decreased appetite—Doxorubicin—bone cancer	7.72e-05	0.000401	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—bone cancer	7.67e-05	0.000398	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—bone cancer	7.66e-05	0.000397	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—bone cancer	7.63e-05	0.000396	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—bone cancer	7.6e-05	0.000394	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—bone cancer	7.6e-05	0.000394	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—bone cancer	7.59e-05	0.000394	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—bone cancer	7.59e-05	0.000394	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—bone cancer	7.56e-05	0.000392	CcSEcCtD
Ofloxacin—Asthenia—Methotrexate—bone cancer	7.36e-05	0.000382	CcSEcCtD
Ofloxacin—Feeling abnormal—Doxorubicin—bone cancer	7.32e-05	0.00038	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.29e-05	0.00191	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	7.26e-05	0.000377	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—bone cancer	7.26e-05	0.000376	CcSEcCtD
Ofloxacin—Hypersensitivity—Epirubicin—bone cancer	7.07e-05	0.000367	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—bone cancer	7.06e-05	0.000366	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	7.02e-05	0.00184	CbGpPWpGaD
Ofloxacin—Body temperature increased—Doxorubicin—bone cancer	7.02e-05	0.000364	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—bone cancer	7.02e-05	0.000364	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—bone cancer	7.02e-05	0.000364	CcSEcCtD
Ofloxacin—Asthenia—Epirubicin—bone cancer	6.89e-05	0.000357	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—bone cancer	6.79e-05	0.000352	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—bone cancer	6.78e-05	0.000352	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.73e-05	0.00176	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—bone cancer	6.57e-05	0.000341	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—bone cancer	6.54e-05	0.000339	CcSEcCtD
Ofloxacin—Vomiting—Methotrexate—bone cancer	6.52e-05	0.000338	CcSEcCtD
Ofloxacin—Rash—Methotrexate—bone cancer	6.47e-05	0.000336	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—bone cancer	6.46e-05	0.000335	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	6.43e-05	0.00168	CbGpPWpGaD
Ofloxacin—Headache—Methotrexate—bone cancer	6.43e-05	0.000333	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—bone cancer	6.37e-05	0.000331	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—bone cancer	6.35e-05	0.000329	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—bone cancer	6.28e-05	0.000326	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	6.12e-05	0.0016	CbGpPWpGaD
Ofloxacin—Vomiting—Epirubicin—bone cancer	6.1e-05	0.000317	CcSEcCtD
Ofloxacin—Nausea—Methotrexate—bone cancer	6.09e-05	0.000316	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—bone cancer	6.08e-05	0.000315	CcSEcCtD
Ofloxacin—Rash—Epirubicin—bone cancer	6.05e-05	0.000314	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—bone cancer	6.05e-05	0.000314	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	6.04e-05	0.00158	CbGpPWpGaD
Ofloxacin—Headache—Epirubicin—bone cancer	6.01e-05	0.000312	CcSEcCtD
Ofloxacin—Dizziness—Doxorubicin—bone cancer	5.87e-05	0.000305	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	5.75e-05	0.00151	CbGpPWpGaD
Ofloxacin—Nausea—Epirubicin—bone cancer	5.7e-05	0.000296	CcSEcCtD
Ofloxacin—Vomiting—Doxorubicin—bone cancer	5.65e-05	0.000293	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.65e-05	0.00148	CbGpPWpGaD
Ofloxacin—Rash—Doxorubicin—bone cancer	5.6e-05	0.000291	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—bone cancer	5.6e-05	0.00029	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	5.59e-05	0.00146	CbGpPWpGaD
Ofloxacin—Headache—Doxorubicin—bone cancer	5.56e-05	0.000289	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.52e-05	0.00145	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.52e-05	0.00145	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	5.42e-05	0.00142	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—bone cancer	5.28e-05	0.000274	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.24e-05	0.00137	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.16e-05	0.00135	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RB1—bone cancer	5e-05	0.00131	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	4.26e-05	0.00112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ENO2—bone cancer	4.19e-05	0.0011	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DHFR—bone cancer	3.88e-05	0.00102	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NDUFA12—bone cancer	3.67e-05	0.000962	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ENO2—bone cancer	3.51e-05	0.000919	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—DHFR—bone cancer	3.25e-05	0.000853	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GNA11—bone cancer	3.04e-05	0.000797	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NT5C3A—bone cancer	3.04e-05	0.000797	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFBR2—bone cancer	2.82e-05	0.000738	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP3A4—bone cancer	2.76e-05	0.000723	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.74e-05	0.000719	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—bone cancer	2.44e-05	0.000641	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—bone cancer	2.36e-05	0.000618	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KIT—bone cancer	1.92e-05	0.000503	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—bone cancer	1.81e-05	0.000473	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MDM2—bone cancer	1.51e-05	0.000397	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—bone cancer	1.46e-05	0.000382	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO2—bone cancer	1.33e-05	0.000349	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—DHFR—bone cancer	1.24e-05	0.000324	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—bone cancer	1.22e-05	0.00032	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GNA11—bone cancer	1.15e-05	0.000303	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000274	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.04e-05	0.000273	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—bone cancer	1.03e-05	0.000271	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—bone cancer	8.95e-06	0.000235	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—bone cancer	4.64e-06	0.000122	CbGpPWpGaD
